中国基层医药
中國基層醫藥
중국기층의약
Chinese Journal of Primary Medicine and Pharmacy
2015年
21期
3302-3304
,共3页
前列腺增生症%经尿道前列腺等离子双极电切%经尿道前列腺电切
前列腺增生癥%經尿道前列腺等離子雙極電切%經尿道前列腺電切
전렬선증생증%경뇨도전렬선등리자쌍겁전절%경뇨도전렬선전절
Benign prostatic hyperplasia%TUPKP%TURP
目的：探讨良性前列腺增生症应用经尿道前列腺等离子双极电切（TUPKP）治疗的临床效果，为临床选择术式提供参考。方法选择100例良性前列腺增生患者，按照治疗术式分为对照组与观察组，对照组50例采用 TURP 术式治疗，观察组50例患者采用 TUPKP 术式治疗，术后随访3个月，对比两组患者留置尿管时间、腺体组织质量等临床指标，对比两组生活质量指数、国际前列腺症状评分、并发症等指标。结果观察组手术时间（60．54±8．37）min、术中出血量（108．43±21．37）mL、住院时间（7．09±2．35）d，均优于对照组的（70．24±12．22）min、（188．76±21．36）mL、（8．63±2．76）d，两组差异均有统计学意义（t ＝5．441，P ＝0.012；t ＝8．326，P ＝0．001；t ＝6．216，P ＝0．006）；术后观察3个月，观察组最大尿流率（19．05±4．11）mL／s、残留尿量（28．74±4．55）mL、IPSS（5．12±1．27）分、QOL（1．43±0．24）分，均优于对照组的（14．24±3．77）mL／s、（20．85±5．11）mL、IPSS（6．95±1．44）分、QOL（2．03±0．32）分，两组差异均有统计学意义（t ＝8．763，P ＝0.000；t ＝7．616，P ＝0．003；t ＝5．472，P ＝0．011；t ＝8．044，P ＝0．002）；观察组并发症发生率为10．00％，明显低于对照组的22．00％，两组差异有统计学意义（χ2＝5．437，P ＝0．012）。结论TUPKP 治疗良性前列腺增生症临床效果显著，可有效改善患者临床症状及生活质量，安全性高，值得临床推广应用。
目的：探討良性前列腺增生癥應用經尿道前列腺等離子雙極電切（TUPKP）治療的臨床效果，為臨床選擇術式提供參攷。方法選擇100例良性前列腺增生患者，按照治療術式分為對照組與觀察組，對照組50例採用 TURP 術式治療，觀察組50例患者採用 TUPKP 術式治療，術後隨訪3箇月，對比兩組患者留置尿管時間、腺體組織質量等臨床指標，對比兩組生活質量指數、國際前列腺癥狀評分、併髮癥等指標。結果觀察組手術時間（60．54±8．37）min、術中齣血量（108．43±21．37）mL、住院時間（7．09±2．35）d，均優于對照組的（70．24±12．22）min、（188．76±21．36）mL、（8．63±2．76）d，兩組差異均有統計學意義（t ＝5．441，P ＝0.012；t ＝8．326，P ＝0．001；t ＝6．216，P ＝0．006）；術後觀察3箇月，觀察組最大尿流率（19．05±4．11）mL／s、殘留尿量（28．74±4．55）mL、IPSS（5．12±1．27）分、QOL（1．43±0．24）分，均優于對照組的（14．24±3．77）mL／s、（20．85±5．11）mL、IPSS（6．95±1．44）分、QOL（2．03±0．32）分，兩組差異均有統計學意義（t ＝8．763，P ＝0.000；t ＝7．616，P ＝0．003；t ＝5．472，P ＝0．011；t ＝8．044，P ＝0．002）；觀察組併髮癥髮生率為10．00％，明顯低于對照組的22．00％，兩組差異有統計學意義（χ2＝5．437，P ＝0．012）。結論TUPKP 治療良性前列腺增生癥臨床效果顯著，可有效改善患者臨床癥狀及生活質量，安全性高，值得臨床推廣應用。
목적：탐토량성전렬선증생증응용경뇨도전렬선등리자쌍겁전절（TUPKP）치료적림상효과，위림상선택술식제공삼고。방법선택100례량성전렬선증생환자，안조치료술식분위대조조여관찰조，대조조50례채용 TURP 술식치료，관찰조50례환자채용 TUPKP 술식치료，술후수방3개월，대비량조환자류치뇨관시간、선체조직질량등림상지표，대비량조생활질량지수、국제전렬선증상평분、병발증등지표。결과관찰조수술시간（60．54±8．37）min、술중출혈량（108．43±21．37）mL、주원시간（7．09±2．35）d，균우우대조조적（70．24±12．22）min、（188．76±21．36）mL、（8．63±2．76）d，량조차이균유통계학의의（t ＝5．441，P ＝0.012；t ＝8．326，P ＝0．001；t ＝6．216，P ＝0．006）；술후관찰3개월，관찰조최대뇨류솔（19．05±4．11）mL／s、잔류뇨량（28．74±4．55）mL、IPSS（5．12±1．27）분、QOL（1．43±0．24）분，균우우대조조적（14．24±3．77）mL／s、（20．85±5．11）mL、IPSS（6．95±1．44）분、QOL（2．03±0．32）분，량조차이균유통계학의의（t ＝8．763，P ＝0.000；t ＝7．616，P ＝0．003；t ＝5．472，P ＝0．011；t ＝8．044，P ＝0．002）；관찰조병발증발생솔위10．00％，명현저우대조조적22．00％，량조차이유통계학의의（χ2＝5．437，P ＝0．012）。결론TUPKP 치료량성전렬선증생증림상효과현저，가유효개선환자림상증상급생활질량，안전성고，치득림상추엄응용。
Objective To investigate clinical value of transurethral bipolar plasma cutting and transurethral resection for benign prostatic hyperplasia,to provide a reference for clinical treatment.Methods 100 cases with benign prostatic hyperplasia were selected,according to surgical treatment,they were divided into control group and observation group.50 patients in the control group received TURP surgical treatment,50 patients in the observation group were given TUPKP surgical treatment.The patients were followed up for 3 months,the indwelling catheter time, weight and other clinical indicators of glandular tissue were compared,serum sodium and hemoglobin levels were observed,the quality of life index,international Prostate Symptom Score,complications and other indicators were compared. Results In the observation group,operative time was (60.54 ±8.37)min,blood loss was (108.43 ±21.27)mL, hospital stay was (7.09 ±2.25)d,which were shorter than those of the control group (70.24 ±12.22)min,(188.76 ± 21.36)mL,(8.63 ±2.76)d,the differences were statistically significant (t =5.441,P =0.012;t =8.326,P =0.001;t =6.216,P =0.006).In the observation group after three months,maximum flow rate was (18.95 ±4.11)mL/s, residual urine volume was (28.74 ±4.55)mL,IPSS was (5.12 ±1.27)points,QOL was (1.43 ±0.24)scores, which were better than those of the control group (14.24 ±3.77)mL/s,(20.85 ±5.11)mL,IPSS(6.95 ±1.44)points, QOL(2.03 ±0.32)points,the differences were statistically significant (t =8.763,P =0.000;t =7.616,P =0.003;t =5.472,P =0.011;t =8.044,P =0.002).The incidence rate of complication in the observation group was 10.00%, which was significantly lower than 22.00% in the control group,the difference was statistically significant (χ2 =5.437,P =0.012).Conclusion TUPKP treatment for benign prostatic hyperplasia has significant clinical effect, which can effectively improve the clinical symptoms and quality of life with good safety,it is worthy of clinical application.
